Localized topical steroid use and central serous retinopathy
Lauren Y Chan1, Robert S Adam2, David N Adam3
1a School of Medicine, Queen's University , Kingston , ON , Canada .
The Journal of Dermatological Treatment
|January 30, 2016
Summary
Topical steroid use, even in limited areas, may be linked to central serous retinopathy (CSR). This finding highlights the importance of considering ocular side effects with dermatological treatments.
Area of Science:
- Ophthalmology
- Dermatology
- Retinal Diseases
Background:
- Central serous retinopathy (CSR) is a common retinal disease causing vision loss due to subretinal fluid accumulation.
- CSR is typically associated with systemic corticosteroid use (oral or inhaled).
- The relationship between localized topical steroid use and CSR is not well-established due to limited case reports.
Observation:
- This case series reviews two patients who developed CSR following the use of topical steroids.
- These patients used topical steroids on limited body areas, differentiating them from previously reported cases.
Findings:
- Consistent use of topical steroids, even on localized areas, is associated with the development of CSR.
- These unique cases suggest a broader association between topical corticosteroid application and CSR.
Implications:
- Dermatologists must be aware of the potential link between topical steroid prescriptions and CSR.
- Patients using topical steroids who develop ocular symptoms should be promptly referred to ophthalmology for evaluation.
- This underscores the need for careful patient monitoring and consideration of steroid-induced ocular complications.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:23Ophthalmic Drug Delivery Systems
211
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
211
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K